Weisblum Eric's Form 4 filing
Silo Pharma, Inc. (SILO) · filed May 18, 2023
- Accession no.
- 0001213900-23-041179
- Filed
- May 18, 2023
- Trade date
- May 17-18, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $6.21K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weisblum EricCIK 0001569077 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $2.06 | +$5,150 | 157,224 | Direct | |
| May 18, 2023 | Common Stock | PPurchaseAcquired | +500 | $2.11 | +$1,055 | 157,724 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.